Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0247 per EA under NDC 65862000901. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
850 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862000901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077095On Market Since
1/14/2005
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 35.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0247 per EA |
|---|---|
| All-time high | $0.0436 (Feb 12, 2014) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0294 |
| Average price | $0.0298 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0247 per EA (NDC 65862000901), effective Jun 24, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 35.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Nov 28, 2013, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0436 (Feb 12, 2014), with a median of $0.0294 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
13 NADAC-published products share the same active ingredient, strength, and dosage form as METFORMIN HCL 850 MG TABLET, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 65862000901) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification